FH Foundation’s FOCUS analysis shows that regardless of medical need, prescriptions for PCSK9 inhibitors are being rejected at high rates


Pasadena, Calif. – The Familial Hypercholesterolemia Foundation today published a study in Circulation revealing high rejection rates for PCSK9 inhibitors in the two at-risk patient populations approved for this novel cholesterol-lowering class of therapy.

The FH Foundation’s FOCUS (FH Optimal … Read More

Colleen S.

Avery’s Fight

No Comments

Avery Watts was diagnosed with the rare disease Homozygous Familial Hypercholesterolemia at the age of 6. After her diagnosis, Avery’s life became much more complicated. Luckily, she’s a very strong little girl. Through this project, she hopes to encourage others, especially those with … Read More